Alter Galit, Ananworanich Jintanat, Pantophlet Ralph, Rybicki Ed P, Buonaguro Luigi
Partners AIDS Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
Hum Vaccin. 2009 Mar;5(3):119-25. doi: 10.4161/hv.5.3.7557. Epub 2009 Mar 8.
The "AIDS Vaccine 2008" Conference was held in Cape Town, South Africa (October 13 to 16, 2008) and organized, under the aegis of the Global HIV Vaccine Enterprise, by Dr. Lynn Morris (Chair of the Conference) National Institute of Communicable Diseases; Dr. Koleka Mlisana from CAPRISA, University KwaZulu-Natal, Durban, Dr. Glenda Gray from Perinatal HIV Research Unit, University Witwatersrand, Johannesburg and Dr. Carolyn Williamson from Institute of Infectious Diseses. and Molecular Medicine, UCT, Cape Town (Co-Chairs of the Conference). Since the first AIDS Vaccine conference, organized in Paris in 2000, this was the first time it was held outside of the U.S. and Europe, and involved nearly 1,000 participants. Besides three Plenary Sessions with ten state-of-the-art plenary lectures and one Keynote Lecture given by Dr. A.S. Fauci (Director of NIAID, NIH, USA), the Conference was organized in nine oral sessions, four poster discussion groups covering a wide spectrum of scientific information relating to HIV vaccine research and development. Moreover three Symposia, two Special Sessions, one Roundtable as well as two Debates were held, the latter focusing on current controversial topics. The conference opening was memorable for a number of reasons: among these was the presence of South Africa's new Minister of Health, Barbara Hogan who, in her first speech in a major forum as a senior member of the SA Government, affirmed that HIV causes AIDS, and that the search for a vaccine is of paramount importance to SA and the rest of the world. A scientific summary of the Conference is reported in the present article, divided into four major topics: (1) vaccine concepts and design; (2) T-cell immunology and innate immunity; (3) B-cell immunology, neutralizing antibodies and mucosal immunology; and (4) clinical trials.
“2008年艾滋病疫苗大会”于2008年10月13日至16日在南非开普敦举行,由全球艾滋病毒疫苗企业组织,林恩·莫里斯博士(会议主席,国家传染病研究所)、夸祖鲁 - 纳塔尔大学德班CAPRISA的科莱卡·姆利萨纳博士、约翰内斯堡金山大学围产期艾滋病毒研究单位的格伦达·格雷博士以及开普敦大学传染病与分子医学研究所的卡罗琳·威廉姆森博士(会议联合主席)共同筹备。自2000年在巴黎举办首届艾滋病疫苗大会以来,这是首次在美国和欧洲以外的地区举行,参会人数近1000人。除了三场全会,会上有十场前沿全会演讲以及由美国国立卫生研究院国家过敏和传染病研究所所长A.S. 福西博士发表的一场主题演讲外,大会还组织了九个口头报告环节、四个海报讨论小组,涵盖了与艾滋病毒疫苗研发相关的广泛科学信息。此外,还举办了三场研讨会、两场特别会议、一场圆桌会议以及两场辩论,后者聚焦当前有争议的话题。此次会议开幕式令人难忘,原因有很多:其中包括南非新任卫生部长芭芭拉·霍根出席,她在作为南非政府高级成员的首次重要论坛演讲中确认,艾滋病毒会导致艾滋病,并且寻找疫苗对南非和世界其他地区至关重要。本文报道了该会议的科学总结,分为四个主要主题:(1)疫苗概念与设计;(2)T细胞免疫学与固有免疫;(3)B细胞免疫学、中和抗体与黏膜免疫学;(4)临床试验。